Further, PF-4var but not PF-4 levels are associated with CAD outcome, which is in line with the fact that both CXCR3 ligands differ in biological potency as angiostatic factors and show different affinity for glycosaminoglycans. The gene discussed is CXCR3; the disease is coronary artery disorder.